Literature DB >> 12563258

PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction.

Harumi Suzuki1, Satoshi Matsuda, Yasuo Terauchi, Mari Fujiwara, Toshiaki Ohteki, Tomoichiro Asano, Timothy W Behrens, Taku Kouro, Kiyoshi Takatsu, Takashi Kadowaki, Shigeo Koyasu.   

Abstract

Phosphoinositide-3 kinase (PI3K) is thought to activate the tyrosine kinase Btk. However, through analysis of PI3K-/- and Btk-/- mice, B cell antigen receptor (BCR)-induced activation of Btk in mouse B cells was found to be unaffected by PI3K inhibitors or by a lack of PI3K. Consistent with this observation, PI3K-/- Btk-/- double-deficient mice had more severe defects than either single-mutant mouse. NF-kappaB activation along with Bcl-xL and cyclin D2 induction were severely blocked in both PI3K-/- and Btk-/- single-deficient B cells. Transgenic expression of Bcl-xL restored the development and BCR-induced proliferation of B cells in PI3K-/- mice. Our results indicate that PI3K and Btk have unique roles in proximal BCR signaling and that they have a common target further downstream in the activation of NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12563258     DOI: 10.1038/ni890

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  37 in total

1.  A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation.

Authors:  Shuling Guo; Gregory Z Ferl; Rajendar Deora; Mireille Riedinger; Sheng Yin; James L Kerwin; Joseph A Loo; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-16       Impact factor: 11.205

2.  CD19 controls Toll-like receptor 9 responses in human B cells.

Authors:  Henner Morbach; Jean-Nicolas Schickel; Charlotte Cunningham-Rundles; Mary Ellen Conley; Ismail Reisli; Jose Luis Franco; Eric Meffre
Journal:  J Allergy Clin Immunol       Date:  2015-10-21       Impact factor: 10.793

3.  Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of BTK and PI3Kδ.

Authors:  Brahmam Pujala; Anil K Agarwal; Sandip Middya; Monali Banerjee; Arjun Surya; Anjan K Nayak; Ashu Gupta; Sweta Khare; Rambabu Guguloth; Nitin A Randive; Bharat U Shinde; Anamika Thakur; Dhananjay I Patel; Mohd Raja; Michael J Green; Jennifer Alfaro; Patricio Avila; Felipe Pérez de Arce; Ramona G Almirez; Stacy Kanno; Sebastián Bernales; David T Hung; Sarvajit Chakravarty; Emma McCullagh; Kevin P Quinn; Roopa Rai; Son M Pham
Journal:  ACS Med Chem Lett       Date:  2016-10-28       Impact factor: 4.345

Review 4.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

5.  Foxo1 regulates marginal zone B-cell development.

Authors:  Jing Chen; Jose J Limon; Caroline Blanc; Stanford L Peng; David A Fruman
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

Review 6.  Midkine as a regulator of B cell survival in health and disease.

Authors:  Sivan Cohen; Idit Shachar
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

7.  B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy.

Authors:  Leo Zhang; Krystle Nomie; Hui Zhang; Taylor Bell; Lan Pham; Sabah Kadri; Jeremy Segal; Shaoying Li; Shouhao Zhou; David Santos; Shawana Richard; Shruti Sharma; Wendy Chen; Onyekachukwu Oriabure; Yang Liu; Shengjian Huang; Hui Guo; Zhihong Chen; Wenjing Tao; Carrie Li; Jack Wang; Bingliang Fang; Jacqueline Wang; Lei Li; Maria Badillo; Makhdum Ahmed; Selvi Thirumurthi; Steven Y Huang; Yiping Shao; Laura Lam; Qing Yi; Y Lynn Wang; Michael Wang
Journal:  Clin Cancer Res       Date:  2017-03-27       Impact factor: 12.531

8.  Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection.

Authors:  Laurent Verkoczy; Bao Duong; Patrick Skog; Djemel Aït-Azzouzene; Kamal Puri; José Luis Vela; David Nemazee
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

9.  Protein kinase N1, a cell inhibitor of Akt kinase, has a central role in quality control of germinal center formation.

Authors:  Teruhito Yasui; Kaori Sakakibara-Yada; Taki Nishimura; Kentaro Morita; Satoru Tada; George Mosialos; Elliott Kieff; Hitoshi Kikutani
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-05       Impact factor: 11.205

10.  Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.

Authors:  Wan Cheung Cheung; Joong Su Kim; Michael Linden; Liangping Peng; Brian Van Ness; Roberto D Polakiewicz; Siegfried Janz
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.